CDIX · Cardiff Lexington Corp
$0.03
+0.01 (+50.00%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have sustained operating losses since inception and have an accumulated deficit of $85,617,319 as of June 30, 2026 and have a negative cash flow from operations of $668,649 for the six months ended June 30, 2026. These factors raise a substantial doubt about our company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$469,120
Shares
15.64M
Volume · Oct 21
248.01K
Avg daily vol (3M)
44.32K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.03
Open$0.03
Day$0.02–0.03
52W close$0.02–5.62
Avg vol 30d64K
Short int83 · 0.0% float · 1.0d
Short vol16%
Last earningsMay 19, 2026
DataNov 2020–Oct 2026
Filing10-Q · Aug 12
Up next
filed Aug 12, 2026
call held May 19, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$10.21M
Trailing 12 months
Net income (TTM)
−$9.40M
Trailing 12 months
Revenue growth YoY
-22.6%
Year over year
Operating margin
-10.9%
Trailing 12 months
P / E (TTM)
24.0
Trailing earnings · reciprocal yield 4.2%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$22.51M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+146.6%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−99%
below
Price vs 50-day avg
−92%
below
RSI (14)
36
neutral
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−95%
trailing
6-month return
−99%
trailing
YTD return
−99%
this year
Relative strength
−107%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $3 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
11
low risk · 0–100
Fundamentals
Revenue growth
+39%
Y/Y
Gross margin
62%
expanding
EPS growth
+100%
Y/Y
Free cash flow
$-1.7M
Balance sheet
$18.2M
net debt
Quant / Vol
risk profile
Volatility
570%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
224.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−99%
Bearish
Price vs 50-day avg
−92%
Bearish
RSI (14)
36
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $3 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $6
vs 200-day avg -99%
vs 50-day avg -92%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CDIX
this stock
Cardiff Lexington Corp
|
$469,120 | — | +39.5% | — | 0.0% |
|
HCA
HCA Healthcare, Inc.
|
$101.91B | +0.1% | +7.1% | 15.4 | 2.2% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.97B | -10.3% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.49B | +36.2% | +0.9% | 10.3 | 2.3% |
|
EHC
Encompass Health Corp
|
$12.43B | +18.7% | +10.5% | 20.5 | 3.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CDIX | -36.2% | -95.4% | -99.3% | -78.2% | -99.5% |
| SPY | +0.5% | +0.7% | +7.6% | +1.4% | +13.4% |
| vs SPY | -36.6% | -96.1% | -106.8% | -79.6% | -112.8% |